Advertisement

FDA to step up fentanyl targeting at postal facilities

Share This Page
To enhance FDA's ability to detect opioid analgesics illegally entering the country via the mail, the agency is deploying roughly three dozen employees to international mail facilities run by the U.S. Postal Service, according to FDA Commissioner Scott Gottlieb's recent internal remarks.

To enhance FDA's ability to detect opioid analgesics illegally entering the country via the mail, the agency is deploying roughly three dozen employees to international mail facilities run by the U.S. Postal Service, according to FDA Commissioner Scott Gottlieb's recent internal remarks. The employees will help detect and analyze suspicious packages, and will also be sent to FDA's cybercrime and forensic-chemistry units. A recent report issued by the White House opioid commission stated, "Our inability to reliably detect fentanyl at our land borders and at our international mail handling facilities creates untenable vulnerabilities." Meanwhile. Sen. Rob Portman (R-OH) is backing a bipartisan bill called the STOP Act that calls for foreign postal services to provide electronic security data on all packages shipped to the United States. Separate legislation would equip customs officials with high-tech chemical screening devices to help detect illicit opioid analgesics.

Ad Position: 
Bottom Center Aligned
https://www.washingtonpost.com/news/to-your-health/wp/2017/08/04/fda-to-step-up-fentanyl-targeting-at-postal-facilities/?utm_term=.c1defaaff776

Advertisement

Related Content

block-views-related-content-block